Gliquidone

Gliquidone is an anti-diabetic medication used in the management of Type 2 diabetes. It belongs to the class of drugs known as sulfonylureas, which work by stimulating the release of insulin from the pancreas.

Etymology

The term 'Gliquidone' is derived from the chemical name '1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methoxyphenylsulfonyl)urea'. The name 'Gliquidone' is a combination of parts of this chemical name.

Pharmacology

Gliquidone works by stimulating the release of insulin from the pancreas. It does this by binding to the ATP-dependent K+ (potassium) channels on the surface of the beta cells in the pancreas. This causes the channels to close, leading to depolarization of the cell membrane, calcium influx, and subsequent insulin release.

Indications

Gliquidone is indicated for the treatment of Type 2 diabetes in adults. It is used when diet and exercise alone does not provide adequate glycemic control. It can be used alone or in combination with other anti-diabetic medications.

Side Effects

Common side effects of Gliquidone include hypoglycemia, nausea, diarrhea, and abdominal pain. Rare but serious side effects include jaundice, thrombocytopenia, and leukopenia.

Contraindications

Gliquidone is contraindicated in patients with Type 1 diabetes or diabetic ketoacidosis. It is also contraindicated in patients with severe renal impairment or severe hepatic impairment.

Related Terms

• Sulfonylureas
• Insulin
• Type 2 diabetes
• Hypoglycemia
• Diabetic ketoacidosis

Gliquidone Resources
Latest articles Most recent articles Ongoing trials	Wikipedia